These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31693911)

  • 1. Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820.
    Du X; Volkov OA; Czerwinski RM; Tan H; Huerta C; Morton ER; Rizzi JP; Wehn PM; Xu R; Nijhawan D; Wallace EM
    Structure; 2019 Nov; 27(11):1625-1633.e3. PubMed ID: 31693911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
    Faust TB; Yoon H; Nowak RP; Donovan KA; Li Z; Cai Q; Eleuteri NA; Zhang T; Gray NS; Fischer ES
    Nat Chem Biol; 2020 Jan; 16(1):7-14. PubMed ID: 31686031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
    Bussiere DE; Xie L; Srinivas H; Shu W; Burke A; Be C; Zhao J; Godbole A; King D; Karki RG; Hornak V; Xu F; Cobb J; Carte N; Frank AO; Frommlet A; Graff P; Knapp M; Fazal A; Okram B; Jiang S; Michellys PY; Beckwith R; Voshol H; Wiesmann C; Solomon JM; Paulk J
    Nat Chem Biol; 2020 Jan; 16(1):15-23. PubMed ID: 31819272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.
    Ting TC; Goralski M; Klein K; Wang B; Kim J; Xie Y; Nijhawan D
    Cell Rep; 2019 Nov; 29(6):1499-1510.e6. PubMed ID: 31693891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
    Han T; Goralski M; Gaskill N; Capota E; Kim J; Ting TC; Xie Y; Williams NS; Nijhawan D
    Science; 2017 Apr; 356(6336):. PubMed ID: 28302793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide.
    Jang JH; Kim JY; Lee TJ
    Genes Genomics; 2024 Dec; 46(12):1345-1361. PubMed ID: 39271535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4
    Kim SA; Jo SH; Cho JH; Yu MY; Shin HC; Kim JA; Park SG; Park BC; Kim S; Kim JH
    Mol Cells; 2020 Nov; 43(11):935-944. PubMed ID: 33168788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximity Labeling, Quantitative Proteomics, and Biochemical Studies Revealed the Molecular Mechanism for the Inhibitory Effect of Indisulam on the Proliferation of Gastric Cancer Cells.
    Lu J; Jiang H; Li D; Chen T; Wang Y; Pu Z; Xu G
    J Proteome Res; 2021 Sep; 20(9):4462-4474. PubMed ID: 34420308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding motif protein 39 (RBM39): An emerging cancer target.
    Xu Y; Nijhuis A; Keun HC
    Br J Pharmacol; 2022 Jun; 179(12):2795-2812. PubMed ID: 33238031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.
    Kohsaka S; Yagishita S; Shirai Y; Matsuno Y; Ueno T; Kojima S; Ikeuchi H; Ikegami M; Kitada R; Yoshioka KI; Toshimitsu K; Tabata K; Yokoi A; Doi T; Yamamoto N; Owa T; Hamada A; Mano H
    NPJ Precis Oncol; 2024 May; 8(1):117. PubMed ID: 38789724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases.
    Eléouët M; Lu C; Zhou Y; Yang P; Ma J; Xu G
    Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194902. PubMed ID: 36535628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native mass spectrometry of complexes formed by molecular glues reveals stoichiometric rearrangement of E3 ligases.
    Jackson C; Beveridge R
    Analyst; 2024 May; 149(11):3178-3185. PubMed ID: 38639441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pSILAC method coupled with two complementary digestion approaches reveals PRPF39 as a new E7070-dependent DCAF15 substrate.
    Jia X; Pan L; Zhu M; Hu H; Zhai L; Liu J; Hu M; Liu B; Tan M
    J Proteomics; 2020 Jan; 210():103545. PubMed ID: 31626998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
    Ji T; Yang Y; Yu J; Yin H; Chu X; Yang P; Xu L; Wang X; Hu S; Li Y; Wu X; Liu W; Zhou B; Wang W; Zhang S; Cheng W; Chen Y; Shi L; Li Z; Zhuo R; Zhang Y; Tao Y; Wu D; Li X; Zhang Z; Fan JJ; Pan J; Lu J
    J Exp Clin Cancer Res; 2024 Jul; 43(1):205. PubMed ID: 39044280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and compound screens uncover factors modulating cancer cell response to indisulam.
    Pogacar Z; Groot K; Jochems F; Dos Santos Dias M; Mulero-Sánchez A; Morris B; Roosen M; Wardak L; De Conti G; Velds A; Lieftink C; Thijssen B; Beijersbergen RL; Bernards R; Leite de Oliveira R
    Life Sci Alliance; 2022 Sep; 5(9):. PubMed ID: 35534224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective degradation of splicing factor CAPERα by anticancer sulfonamides.
    Uehara T; Minoshima Y; Sagane K; Sugi NH; Mitsuhashi KO; Yamamoto N; Kamiyama H; Takahashi K; Kotake Y; Uesugi M; Yokoi A; Inoue A; Yoshida T; Mabuchi M; Tanaka A; Owa T
    Nat Chem Biol; 2017 Jun; 13(6):675-680. PubMed ID: 28437394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aryl sulfonamide indisulam inhibits gastric cancer cell migration by promoting the ubiquitination and degradation of the transcription factor ZEB1.
    Lu J; Li D; Jiang H; Li Y; Lu C; Chen T; Wang Y; Wang X; Sun W; Pu Z; Qiao C; Ma J; Xu G
    J Biol Chem; 2023 Apr; 299(4):103025. PubMed ID: 36805336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
    Nijhuis A; Sikka A; Yogev O; Herendi L; Balcells C; Ma Y; Poon E; Eckold C; Valbuena GN; Xu Y; Liu Y; da Costa BM; Gruet M; Wickremesinghe C; Benito A; Kramer H; Montoya A; Carling D; Want EJ; Jamin Y; Chesler L; Keun HC
    Nat Commun; 2022 Mar; 13(1):1380. PubMed ID: 35296644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
    Singh S; Quarni W; Goralski M; Wan S; Jin H; Van de Velde LA; Fang J; Wu Q; Abu-Zaid A; Wang T; Singh R; Craft D; Fan Y; Confer T; Johnson M; Akers WJ; Wang R; Murray PJ; Thomas PG; Nijhawan D; Davidoff AM; Yang J
    Sci Adv; 2021 Nov; 7(47):eabj5405. PubMed ID: 34788094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
    Bussiere DE; Xie L; Srinivas H; Shu W; Burke A; Be C; Zhao J; Godbole A; King D; Karki RG; Hornak V; Xu F; Cobb J; Carte N; Frank AO; Frommlet A; Graff P; Knapp M; Fazal A; Okram B; Jiang S; Michellys PY; Beckwith R; Voshol H; Wiesmann C; Solomon JM; Paulk J
    Nat Chem Biol; 2020 Mar; 16(3):361. PubMed ID: 31942047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.